The current research indicates that E2 upregulates the ERα/SIRT1/PGC-1α signaling pathway and protects mitochondrial function to prevent OVX-induced NAFLD. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.